There have been reports of other complement proteins acting intracellularly, such as C1s being recently identified as a prognostic marker in renal cancer, where expression was linked to poorer prognosis, a more aggressive cancer cell phenotype, and possibly increased C4d generation.47 This evidence concerns the gene C1S and cancer.